Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2003
11/11/2003US6645745 Cytochrome P-450 (CYP) heme proteins mediating a varitey of metabolic processes; use to identify/obtain drug candidates or inhibitors for therapy of disorders related to malfunction of human CYP encoding genes such as cancer
11/11/2003US6645739 Genetic engineering; for production of enzymes, growth factors, cytokines, immunogenic proteins, and immunoglobulin proteins
11/11/2003US6645736 Calcium independent cytosolic phospholipase A2/B enzymes
11/11/2003US6645728 Genetically engineered enzymatic protein; for use in modulating apotosis, swelling and immune response
11/11/2003US6645501 Anti-pathogen system and methods of use thereof
11/11/2003CA2293695C Protease enzymes for tough cleaning and/or spot and film reduction and compositions incorporating same
11/11/2003CA2132344C Super porous polysaccharide gels
11/06/2003WO2003091835A2 Computationally targeted evolutionary design
11/06/2003WO2003091459A1 Cells for detection of influenza and parainfluenza viruses
11/06/2003WO2003091441A1 Sfr2 protein encoding gene
11/06/2003WO2003091436A1 Novel 35 kd protein
11/06/2003WO2003091431A1 Methylotroph producing mammalian type sugar chain
11/06/2003WO2003091423A1 Adh from rhodococcus erythropolis
11/06/2003WO2003091422A1 Mutated alkaline cellulase
11/06/2003WO2003091420A2 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides
11/06/2003WO2003091419A2 Kinases and phosphatases
11/06/2003WO2003091418A2 Novel essential fungal polynucleotides, polypeptides, and methods of use
11/06/2003WO2003091411A2 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
11/06/2003WO2003091403A2 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/06/2003WO2003091402A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
11/06/2003WO2003091397A2 Methods and compositions for regulating cellular signaling
11/06/2003WO2003091396A2 Polypeptides and biosynthetic pathways
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090688A2 Enhancement of human epidermal melanogenesis
11/06/2003WO2003068153A3 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
11/06/2003WO2003059945A3 Soluble recombinant protein production
11/06/2003WO2003054153A3 Apyrase polypeptides and nucleic acids encoding same
11/06/2003WO2003054139A3 Compositions and methods utilizing dna polymerases
11/06/2003WO2003052092A3 Method for the inactivation of amylase in the presence of protease
11/06/2003WO2003048378A3 Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003023355A3 Serine/threonine hydrolase proteins and screening assays
11/06/2003WO2003020922A3 Enzymes involved in cell wall biosynthesis in filamentous fungi
11/06/2003WO2003020885B1 Identification of sortase gene
11/06/2003WO2003016515A3 Regulation of human glycerol-3-phosphate acyltransferase-like protein
11/06/2003WO2003012071A3 Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
11/06/2003WO2003012031A3 Antisense modulation of stearoyl-coa desaturase expression
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells
11/06/2003WO2003008588A3 Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2003006674A3 CRYSTALS AND STRUCTURES OF ArnB AMINOTRANSFERASES
11/06/2003WO2003006617A3 Crystals and structures of perosamine synthase homologs
11/06/2003WO2003006602A3 Subtilase variants
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2003005880A3 Replikin peptides and uses thereof
11/06/2003WO2003001983A3 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function
11/06/2003WO2002090523A3 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/06/2003WO2002086126A3 Enzymatic method for the enantioselective reduction of keto compounds
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002081741A3 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection
11/06/2003WO2002081714A3 Overexpression of phosphoenolpyruvate carboxylase
11/06/2003WO2002079258A3 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
11/06/2003WO2002068666A8 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes
11/06/2003WO2002068575A8 Liquid detergent composition exhibiting enhanced α-amylase enzyme stability
11/06/2003WO2002066662A8 Process for the preparation of perillyl alcohol
11/06/2003WO2002063025A3 Muscle-directed gene therapy with aav-1 and aav-6 vectors
11/06/2003WO2002061066A8 Method for producing an enzyme from a novel source
11/06/2003WO2002057792A3 Affinity selection-based screening of hydrophobic proteins
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002046437A3 Methods and compositions for highly efficient production of heterologous proteins in yeast
11/06/2003WO2002046379A3 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003WO2002009639A3 Methods and pharmaceutical compositions for healing wounds
11/06/2003WO2002004648A8 Methods for regulating beta-oxidation in plants
11/06/2003US20030208794 Gene targeting using replicating DNA molecules
11/06/2003US20030208791 Enzymes involved in triterpene synthesis
11/06/2003US20030208788 Comprises substitutions in a number of positions corresponding to a position in the phytase; variants are of improved properties like higher thermostability; used in animal feeds
11/06/2003US20030208057 Mammalian genes modulated during fasting and feeding
11/06/2003US20030208056 Two novel camp-specific phosphodiesterase (pde4b)isoforms and related technology
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208044 Galectin 11
11/06/2003US20030207947 Production of lutein in microorganisms
11/06/2003US20030207840 Solid tumors and other conditions related to angiogenesis, including wounds, bone fractures, follicular development, ischemia, retinopathy, psoriasis, and rheumatoid arthritis are treated or detected with reagents which either detect,
11/06/2003US20030207830 Mutant NDP kinases for antiviral nucleotide analog activation and therapeutic uses thereof
11/06/2003US20030207808 Novel nucleic acid and amino acid sequences
11/06/2003US20030207806 Insecticidal protein toxins from Photorhabdus
11/06/2003US20030207800 Proteins, polynucleotides encoding them and methods of using the same
11/06/2003US20030207796 Specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X
11/06/2003US20030207442 Method for detecting the presence of an analyte in a sample
11/06/2003US20030207437 Preparation of acariogenic sugar substitutes
11/06/2003US20030207436 From an N-acyl-D-amino acid, wherein a minimum reaction rate is specified when forming D-tryptophan from N-acetyl-D-tryptophan in an aqueous medium
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207433 Nucleotide-sugar-synthesizing enzymes from nonparasitic protists
11/06/2003US20030207432 For refractory injuries, having human leukocyte elastase inhibitory activity
11/06/2003US20030207430 For diagnosis, therapy, and prevention of disorders related to aberrant expression
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same